Director Accounting at CureVac AG - Boston, MA, US
Scientist Lung Therapeutics
Contact Carmen Veith
Drug Product Manager
Contact Giovanni Zorzi
Manager Finance
Contact Judith Wilke
Vice President Patents
Contact Marcus Dalton
Chief Scientific Officer
Contact Igor Splawski
Senior Scientist Clinical Immunomonitoring
Contact Sandra Lazzaro
Group Manager GMP Service Provider
Contact Julia Walz
CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.